Mizuho on Axsome Therapeutics (AXSM): 'recommend buying ahead of AXSM's 3Q print'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: AXSM) | Delayed: 155.87 -0.44 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.31 | 52 Week High | $15.74 | |||
| Open | $156.13 | 52 Week Low | $5.37 | |||
| Day High | $158.08 | P/E | N/A | |||
| Day Low | $155.06 | EPS | $0.00 | |||
| Volume | 117,039 | |||||
